Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
THAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GABRR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL13RA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH2B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EBAG9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CADM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAS2R50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRG1BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
VWA3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on